Literature DB >> 7048047

Release of endotoxic lipopolysaccharide by sensitive strains of Escherichia coli submitted to the bactericidal action of human serum.

J Demonty, J De Graeve.   

Abstract

Free endotoxin was assayed in filtered samples of E. coli suspensions submitted to the bactericidal and bacteriolytic action of 10% human serum. The Limulus amoebocyte lysate test, a passive hemolysis inhibition assay based on O antigenic specificity and the determination of 3-OH-myristic acid by mass spectrometry were used as assay methods differing from one another with regard to the part of the endotoxin macromolecule involved in the reaction. The biological activity of endotoxin was assessed in a mouse lethality test. The bactericidal and bacteriolytic action of human serum on sensitive strains of E. coli released quantities of endotoxic lipopolysaccharide (LPS) amounting to 3,000-12,000 ng/ml, for an inoculum of 1--3 x 10(8) colony-forming units. The material thus appearing in the medium was shown to react with the Limulus amoebocyte lysate, to be lethal for actinomycin D-sensitized mice and to bear O antigen, as well as 3-OH-myristic acid, a marker of lipid A. Samples of serum depleted of lysozyme by adsorption onto bentonite, and displaying a strictly bactericidal effect, released approximately 80% of the quantity of LPS appearing in the medium in a control experiment performed with untreated serum. The LPS release is therefore mainly linked to the bactericidal effect of antibody and complement. The amount of LPS released depended on the concentration of divalent cations in the medium, being reduced by an increase in the concentration of calcium and magnesium beyond the values optimal for complement activity. This effect was already observed for an increase in the concentration of divalent cations too low to alter the bactericidal or bacteriolytic effects. The significance of the release of endotoxin by complement dependent bactericidal reactions occurring in vivo is discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7048047     DOI: 10.1007/bf02123317

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  25 in total

1.  Sensitization of complement-resistant smooth gram-negative bacterial strains.

Authors:  B L Reynolds; H Pruul
Journal:  Infect Immun       Date:  1971-03       Impact factor: 3.441

Review 2.  Structure and function of the cell envelope of gram-negative bacteria.

Authors:  J W Costerton; J M Ingram; K J Cheng
Journal:  Bacteriol Rev       Date:  1974-03

3.  The effect of ethylenediaminetetra-acetic acid on the cell walls of some gram-negative bacteria.

Authors:  G W Gray; S G Wilkinson
Journal:  J Gen Microbiol       Date:  1965-06

4.  Comparison of the pyrogenicity, Limulus activity mitogenicity and complement reactivity of several bacterial endotoxins and related compounds.

Authors:  R J Elin; A L Sandberg; D L Rosentreich
Journal:  J Immunol       Date:  1976-10       Impact factor: 5.422

5.  (Omega -2) hydroxylation of fatty acids by a soluble system from bacillus megaterium.

Authors:  Y Miura; A J Fulco
Journal:  J Biol Chem       Date:  1974-03-25       Impact factor: 5.157

6.  Immunologic quantification of gram-negative somatic antigen.

Authors:  J C Guckian; J E Perry
Journal:  Tex Rep Biol Med       Date:  1966

7.  Protective role of complement in experimental Escherichia coli endocarditis.

Authors:  D T Durack; P B Beeson
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

8.  Escherichia coli in bacteremia: K and O antigens and serum sensitivity of strains from adults and neonates.

Authors:  W R McCabe; B Kaijser; S Olling; M Uwaydah; L A Hanson
Journal:  J Infect Dis       Date:  1978-07       Impact factor: 5.226

Review 9.  Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients.

Authors:  B E Kreger; D E Craven; W R McCabe
Journal:  Am J Med       Date:  1980-03       Impact factor: 4.965

10.  Chemical studies on damages of Escherichia coli by the immune bactericidal reaction. I. Release and degradation of phospholipids from damaged bacteria.

Authors:  K Inoue; A Takamizawa; K Yano; T Amano
Journal:  Biken J       Date:  1974-12
View more
  6 in total

1.  Antibiotic-induced release of endotoxin in chronically bacteriuric patients.

Authors:  J C Hurley; W J Louis; F A Tosolini; J B Carlin
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

2.  In vitro reduction of endotoxin concentrations with the 5S fragment of immunoglobulin G.

Authors:  D Xuan; D P Nicolau; P R Tessier; L Bow; R Quintiliani; C H Nightingale
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

3.  Endotoxin shedding by enterobacteria: free and cell-bound endotoxin differ in Limulus activity.

Authors:  I Mattsby-Baltzer; K Lindgren; B Lindholm; L Edebo
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

4.  Role of endotoxemia in cardiovascular dysfunction and lethality: virulent and nonvirulent Escherichia coli challenges in a canine model of septic shock.

Authors:  W D Hoffman; R L Danner; Z M Quezado; S M Banks; R J Elin; J M Hosseini; C Natanson
Journal:  Infect Immun       Date:  1996-02       Impact factor: 3.441

5.  Microwave-induced release and degradation of airborne endotoxins from Escherichia coli bioaerosol.

Authors:  C Wang; Z W Zhang; H Liu
Journal:  J Hazard Mater       Date:  2018-11-23       Impact factor: 10.588

6.  Inactivation of airborne bacteria using different UV sources: Performance modeling, energy utilization, and endotoxin degradation.

Authors:  Can Wang; Siyi Lu; Zhiwei Zhang
Journal:  Sci Total Environ       Date:  2018-11-20       Impact factor: 7.963

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.